GPT Analysis

Empower Your Investments! Unleash the Potential with Smart Stock Analysis!

United States Hong Kong China Singapore Japan India
Sorting Arrows
Symbol
▲ ▼
Company Name Rating
▲ ▼
Recommendation
▲ ▼
Evaluation from GPT Action Time
▲ ▼
TSP TuSimple Holdings Inc - Class A 20 Negative TuSimple Holdings Inc. (TSP) is a trucking company operating in the industrials sector. With a market capitalization of $500 million, TSP has 1,500 full-time employees. The company's financial indicators show negative fundamentals with a trailing EPS of -1.69 and a negative profit margin. TSP's revenue growth is at 48.6%, but it operates at a loss with negative operating margins. The stock's 52-week high is $10.63, but it currently trades around $2.19. With an overall risk rating of 10, PEG ratio of -1.25, and a low target mean price of $3.65, TSP does not appear to be a favorable investment option at the moment.

2023-07-27 03:17:23
TTOO T2 Biosystems Inc 20 Negative T2 Biosystems, Inc. (TTOO) operates in the diagnostics and research industry in the healthcare sector. The company has 158 full-time employees and a market capitalization of $1,841,689. TTOO's stock price has a 52-week range of $0.054 to $15.0, with a current price of $0.074. The stock has experienced a significant decrease in its value over the past year, with a negative 99.08% 52-week change. TTOO has a high short interest, with 9.72% of shares being shorted. The company's financial performance is weak, with negative net income and trailing EPS of -$9.03. TTOO also has a negative forward EPS estimate. Despite the low stock price, the analysis suggests caution due to the high volatility, negative financials, and industry-specific risks.

2023-07-06 07:39:33
UVXY ProShares Ultra VIX Short-Term Futures ETF 2x Shares 20 Negative UVXY is an exchange-traded fund (ETF) that aims to provide investors with two times the daily performance of the S&P 500 VIX Short-Term Futures Index. It is designed to track short-term volatility in the stock market. UVXY has a high beta of -82.46, indicating that it is highly sensitive to market fluctuations. The fund has a negative three-year average return of -0.80% and a negative five-year average return of -0.66%. This suggests that UVXY has not performed well over the long term. The fund's price has been highly volatile, with a 52-week low of $12.80 and a 52-week high of $137.40. Given the fund's negative returns and high volatility, it is not recommended for long-term investment. Investors should consider other options for their portfolio.

2023-10-02 08:45:47
FGEN FibroGen Inc 20 Negative FibroGen, Inc. (FGEN) is a biotechnology company operating in the healthcare sector. The company has a negative profit margin and negative earnings per share, indicating financial difficulties. FGEN's stock price has experienced a significant decline over the past year, with a 52-week change of -93.5%. The company's financial indicators, such as return on assets and return on equity, are also negative, suggesting poor performance. Additionally, FGEN has a high level of debt compared to its total cash. Considering these factors, it is not recommended to invest in FGEN at this time.

2023-10-02 08:43:12
JMIA Jumia Technologies Ag 20 Negative Jumia Technologies AG (JMIA) is a German internet retail company operating in the consumer cyclical sector. The company has a market capitalization of $313.92 million and operates in the internet retail industry. JMIA has a negative profit margin of -0.77% and a negative trailing EPS of -1.62. The company's revenue growth has been negative at -15.4% and it has a high debt-to-equity ratio of 7.43. JMIA's stock price has a 52-week range of $2.55 to $8.15. The stock is currently trading at $3.12, which is close to its 52-week low. The average daily volume for the stock is 1,691,695 shares. Based on these financial indicators, the sentiment for JMIA is negative and the rating is 20 out of 100, indicating a poor investment opportunity.

2023-09-05 09:58:46
MULN Mullen Automotive Inc 20 Negative Mullen Automotive Inc (MULN) has experienced a significant decrease in its stock price over the past year, with a year change of -99.88%. The stock currently trades at $7.82 per share, which is below both the fifty-day average of $14.97 and the two hundred-day average of $383.75. This indicates a strong downward trend in the stock price. The market cap of MULN is $46.02 million, and its shares outstanding are 5,884,690.

Given the current state of the stock, it is not recommended to invest in MULN. The stock has seen a sharp decline, and the market conditions do not appear to be favorable for a recovery. The rating for MULN is 20 out of 100, reflecting the poor performance and outlook for the stock. The sentiment is negative.

2024-01-21 13:44:23
TMF Direxion Daily 20+ Year Treasury Bull 3X Shares 20 Negative TMF is an exchange-traded fund (ETF) that seeks to provide daily investment results, before fees and expenses, of 300% of the performance of the ICE U.S. Treasury 20+ Year Bond Index. It is designed for short-term trading and not suitable for long-term investments. TMF is a leveraged fund, which means it uses borrowed money to amplify its returns. This strategy can lead to higher volatility and increased risk. The fund has a negative year-to-date return of -24.05% and a three-year average return of -47.91%. The fund's price has been declining over the past year, with a 52-week high of $11.87 and a 52-week low of $5.56. Considering the high risk and negative performance, it is not recommended to invest in TMF for long-term investors.

2023-08-28 14:52:12
UVXY ProShares Ultra VIX Short-Term Futures ETF 2x Shares 20 Negative UVXY is an exchange-traded fund (ETF) that aims to provide investors with two times the daily performance of the S&P 500 VIX Short-Term Futures Index. It is designed to track short-term volatility in the stock market. UVXY has a high beta of -82.46, indicating that it is highly sensitive to market fluctuations. The fund has a negative three-year average return of -0.80% and a negative five-year average return of -0.66%. This suggests that UVXY has not performed well over the long term. The fund's price has been highly volatile, with a 52-week low of $12.80 and a 52-week high of $137.40. Given the fund's negative returns and high volatility, it is not recommended for long-term investment. Investors should consider other options for their portfolio.

2023-10-02 08:45:47
MULN Mullen Automotive Inc 20 Negative Mullen Automotive Inc (MULN) has experienced a significant decrease in its stock price over the past year, with a year change of -99.88%. The stock currently trades at $7.82 per share, which is below both the fifty-day average of $14.97 and the two hundred-day average of $383.75. This indicates a strong downward trend in the stock price. The market cap of MULN is $46.02 million, and its shares outstanding are 5,884,690.

Given the current state of the stock, it is not recommended to invest in MULN. The stock has seen a sharp decline, and the market conditions do not appear to be favorable for a recovery. The rating for MULN is 20 out of 100, reflecting the poor performance and outlook for the stock. The sentiment is negative.

2024-01-21 13:44:23
MULN Mullen Automotive Inc 20 Negative Mullen Automotive Inc (MULN) has experienced a significant decrease in its stock price over the past year, with a year change of -99.88%. The stock currently trades at $7.82 per share, which is below both the fifty-day average of $14.97 and the two hundred-day average of $383.75. This indicates a strong downward trend in the stock price. The market cap of MULN is $46.02 million, and its shares outstanding are 5,884,690.

Given the current state of the stock, it is not recommended to invest in MULN. The stock has seen a sharp decline, and the market conditions do not appear to be favorable for a recovery. The rating for MULN is 20 out of 100, reflecting the poor performance and outlook for the stock. The sentiment is negative.

2024-01-21 13:44:23
CSLR Complete Solaria Inc 20 Negative Complete Solaria Inc (CSLR) is a solar technology, services, and installation company. Analyzing the financial indicators, the stock has been on a downward trend, with a year change of -91.74%. The stock's year high was $9.40 and the year low was $0.20. Currently, the stock is trading at $0.45. The stock's 200-day average is $1.63, indicating a significant decline. The market cap is $22.09 million, and the shares outstanding are 49.1 million. The company has experienced losses over the financial years, but industry analysts predict a potential breakeven in the next two years. However, negative equity and accumulated losses on the balance sheet could be a cause for concern. Considering the stock's poor performance and uncertain financials, the sentiment is negative, and the rating for this stock is 20 out of 100.

2024-04-22 03:07:07
BPTH Bio-Path Holdings Inc 20 Negative Bio-Path Holdings Inc. (BPTH) is a company in the healthcare sector with a market capitalization of $2.48 million. The stock has a year high of $21.60 and a year low of $0.93. It is currently trading at $0.97, which is significantly below the 200-day moving average of $5.22. The stock has experienced a year-to-date negative change of -87.24%. The average daily trading volume over the past three months is 1,356,528 shares. The stock is considered highly volatile and has seen a significant decline in value. Based on these indicators, it is not recommended to invest in BPTH at this time.

2024-08-29 09:23:19
AAMC Altisource Asset Management Corp 18 Negative Altisource Asset Management Corp (AAMC) is a company that specializes in providing private credit, particularly in underserved markets. However, the company has faced challenges in recent years, with a significant decline in its stock price. The stock currently trades at a year low of $2.64, which is significantly lower than its year high of $60.88. The company's financial indicators also raise concerns, with a two hundred day average of $20.54, indicating a significant downward trend. With a year change of -0.73, it is evident that AAMC has struggled in the market. Additionally, the stock has a negative sentiment, as reflected in the negative rating. Considering these factors, it is advisable to avoid investing in AAMC at this time.

2024-01-21 13:45:41
AAMC Altisource Asset Management Corp 18 Negative Altisource Asset Management Corp (AAMC) is a company that specializes in providing private credit, particularly in underserved markets. However, the company has faced challenges in recent years, with a significant decline in its stock price. The stock currently trades at a year low of $2.64, which is significantly lower than its year high of $60.88. The company's financial indicators also raise concerns, with a two hundred day average of $20.54, indicating a significant downward trend. With a year change of -0.73, it is evident that AAMC has struggled in the market. Additionally, the stock has a negative sentiment, as reflected in the negative rating. Considering these factors, it is advisable to avoid investing in AAMC at this time.

2024-01-21 13:45:41
AAMC Altisource Asset Management Corp 18 Negative Altisource Asset Management Corp (AAMC) is a company that specializes in providing private credit, particularly in underserved markets. However, the company has faced challenges in recent years, with a significant decline in its stock price. The stock currently trades at a year low of $2.64, which is significantly lower than its year high of $60.88. The company's financial indicators also raise concerns, with a two hundred day average of $20.54, indicating a significant downward trend. With a year change of -0.73, it is evident that AAMC has struggled in the market. Additionally, the stock has a negative sentiment, as reflected in the negative rating. Considering these factors, it is advisable to avoid investing in AAMC at this time.

2024-01-21 13:45:41
AAMC Altisource Asset Management Corp 18 Negative Altisource Asset Management Corp (AAMC) is a company that specializes in providing private credit, particularly in underserved markets. However, the company has faced challenges in recent years, with a significant decline in its stock price. The stock currently trades at a year low of $2.64, which is significantly lower than its year high of $60.88. The company's financial indicators also raise concerns, with a two hundred day average of $20.54, indicating a significant downward trend. With a year change of -0.73, it is evident that AAMC has struggled in the market. Additionally, the stock has a negative sentiment, as reflected in the negative rating. Considering these factors, it is advisable to avoid investing in AAMC at this time.

2024-01-21 13:45:41
AAC-WS Ares Acquisition Corporation - Warrants (01/01/9999) 0 Negative Based on the provided financial indicators, it appears that AAC-WS does not have sufficient data available for analysis. The trailingPegRatio is not provided, and the quoteType is listed as NONE. Without these key indicators, it is difficult to assess the investment potential of AAC-WS. It is recommended to gather more information on the stock or consult with a financial advisor before making any investment decisions.

2023-10-23 00:10:14
AACIU Armada Acquisition Corp I - Units (1 Ord & 1/2 War) 0 Negative Based on the financial indicators provided, it is important to note that AACIU is a shell company with no reported financial activity or trading volume. The lack of financial data and market activity makes it difficult to assess the investment potential of AACIU. Additionally, the company has negative book value, negative earnings per share, and negative return on assets. These factors indicate a lack of profitability and financial stability. Therefore, it is not recommended to invest in AACIU due to the lack of information and unfavorable financial indicators.

2023-07-28 05:39:09
ALPAW Alpha Healthcare Acquisition Corp III - Warrants (01/04/2026) 0 Negative Based on the provided financial indicators for ALPAW, it is difficult to assess the stock's potential for investment. The information given does not provide sufficient data to make an informed decision. Additional financial metrics such as earnings per share, price-to-earnings ratio, and market capitalization are needed to properly evaluate the stock. It is recommended to gather more information and consult with a financial advisor before making any investment decisions.

2023-06-29 23:03:58
AAC-WS Ares Acquisition Corporation - Warrants (01/01/9999) 0 Negative Based on the provided financial indicators, it appears that AAC-WS does not have sufficient data available for analysis. The trailingPegRatio is not provided, and the quoteType is listed as NONE. Without these key indicators, it is difficult to assess the investment potential of AAC-WS. It is recommended to gather more information on the stock or consult with a financial advisor before making any investment decisions.

2023-10-23 00:10:14